跳至主要内容
临床试验/NCT02357134
NCT02357134Unknown2 期

High-Flow Oxygen for Exertional Dyspnea in Cancer Patients

M.D. Anderson Cancer Center1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2015年3月17日最近更新:
适应症
干预措施

试验速览

阶段
2 期
入组人数
74
试验地点
1
主要终点
Modified Borg Scale Dyspnea Intensity at Isotime

研究概览

简要总结

This randomized phase II trial studies how well high-flow oxygen works in reducing difficulty breathing during exercise (exertional dyspnea) in patients with cancer. Dyspnea is linked to decreased lung function, quality of life, and survival. High-flow oxygen is a device that delivers heated and humidified oxygen through the nose. This may be effective in reducing dyspnea, and may help patients' lungs function better and improve their quality of life.

详细描述

PRIMARY OBJECTIVES:

I. Obtain preliminary estimates of the effect size of oxygen and high flow rate on exertional dyspnea (modified Borg Scale adjusted for work rate and baseline dyspnea).

SECONDARY OBJECTIVES:

I. Determine the completion rate of a randomized controlled trial of exertional dyspnea in cancer patients.

II. Obtain preliminary estimates of the effects of oxygen and flow rate on physiologic function (respiratory rate and oxygen saturation) and exercise capacity (work rate and exercise duration).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis of cancer, with evidence of primary or secondary lung involvement
  • •Average dyspnea Borg Scale >= 4 of 10 with severe exertion over the past week
  • •Oxygen saturation > 90% on ambient air at time of assessment
  • •Able to communicate in English or Spanish
  • •Karnofsky performance status >= 50%
  • •Seen at Supportive Care, cardiopulmonary center, thoracic radiation oncology or thoracic medical oncology

排除标准

  • •Resting dyspnea modified Borg Scale > 7 of 10 at enrollment
  • •Severe obstructive lung disease (forced expiratory volume in 1 second [FEV1]/forced vital capacity [FVC] < 70% post bronchodilator and forced expiratory volume in 1 second < 30% predicted)
  • •Delirium (i.e., Memorial Delirium Rating Scale > 13)
  • •History of unstable angina or myocardial infarction in the last week
  • •Acute pulmonary embolus or pulmonary infarction in the last week
  • •Thrombosis of lower extremities in the last week
  • •Acute myocarditis, pericarditis, or endocarditis in the last week
  • •Symptomatic aortic stenosis or syncope in the last week
  • •Suspected dissecting aneurysm
  • •Severe untreated resting arterial hypertension (> 200 mmHg systolic, > 120 mmHg diastolic) at the time of enrollment
  • •Uncontrolled arrhythmias causing symptoms or hemodynamic compromise in the last week
  • •Uncontrolled heart failure in the last week
  • •Pleural effusion requiring thoracentesis within 1 week of study enrollment or scheduled during the study period
  • •Airway obstruction requiring stenting within 1 week of study enrollment or scheduled during the study period
  • •Pneumonia requiring antibiotics at the time of study enrollment

研究组 & 干预措施

Arm I (high-flow oxygen)

Experimental

Patients receive high-flow oxygen via nasal prongs during a structured stationary bicycle exercise session.

干预措施: Quality-of-Life Assessment (Other)

Arm I (high-flow oxygen)

Experimental

Patients receive high-flow oxygen via nasal prongs during a structured stationary bicycle exercise session.

干预措施: Questionnaire Administration (Other)

Arm II (high-flow air)

Experimental

Patients receive high-flow air via nasal prongs during a structured stationary bicycle exercise session

干预措施: Quality-of-Life Assessment (Other)

Arm II (high-flow air)

Experimental

Patients receive high-flow air via nasal prongs during a structured stationary bicycle exercise session

干预措施: Questionnaire Administration (Other)

Arm III (low-flow oxygen)

Active Comparator

Patients receive low-flow oxygen via a nasal cannula during a structured stationary bicycle exercise session.

干预措施: Quality-of-Life Assessment (Other)

Arm III (low-flow oxygen)

Active Comparator

Patients receive low-flow oxygen via a nasal cannula during a structured stationary bicycle exercise session.

干预措施: Questionnaire Administration (Other)

Arm III (low-flow oxygen)

Active Comparator

Patients receive low-flow oxygen via a nasal cannula during a structured stationary bicycle exercise session.

干预措施: Respiratory Therapy (Procedure)

Arm IV (low-flow air)

Active Comparator

Patients receive low-flow air via a nasal cannula during a structured stationary bicycle exercise session.

干预措施: Quality-of-Life Assessment (Other)

Arm IV (low-flow air)

Active Comparator

Patients receive low-flow air via a nasal cannula during a structured stationary bicycle exercise session.

干预措施: Questionnaire Administration (Other)

Arm IV (low-flow air)

Active Comparator

Patients receive low-flow air via a nasal cannula during a structured stationary bicycle exercise session.

干预措施: Respiratory Therapy (Procedure)

Arm II (high-flow air)

Experimental

Patients receive high-flow air via nasal prongs during a structured stationary bicycle exercise session

干预措施: Oxygen Therapy (Procedure)

Arm I (high-flow oxygen)

Experimental

Patients receive high-flow oxygen via nasal prongs during a structured stationary bicycle exercise session.

干预措施: Oxygen Therapy (Procedure)

结局指标

主要结局

Modified Borg Scale Dyspnea Intensity at Isotime

时间窗: End of second exercise test and end of third exercise test, approximately up to 12 minutes

Assessed Dyspnea using the Modified Borg Scale Dyspnea Intensity that ranges from 0 ("no shortness of breath") to 10 ("worst possible shortness of breath") at Isotime. Measured the mean difference of Modified Borg Scale Dyspnea Intensity at isotime between the second exercise test (in which all patients received Low Flow Oxygen) and the third exercise tests (in which all patients received the assigned intervention).

次要结局

  • Slope of Modified Borg Scale Dyspnea Unpleasantness Over Time During Constant Work Exercise Per Minute (Third Test)(Third exercise test, approximately up to 12 minutes)
  • Adverse Events(Before and after 3rd test during intervention phase, approximately up to 12 minutes)
  • Modified Borg Scale Leg Discomfort(Third exercise test, approximately up to 12 minutes)
  • Exercise Endurance(End of third exercise test, approximately up to 12 minutes)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验